Shares of The Cooper Corporations, Inc. (NASDAQ:COO – Get Free Report) hit a brand new 52-week excessive throughout mid-day buying and selling on Thursday following a stronger than anticipated earnings report. The inventory traded as excessive as $104.10 and final traded at $101.61, with a quantity of 23676 shares altering arms. The inventory had beforehand closed at $94.54.
The medical gadget firm reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Corporations had a internet margin of 9.11% and a return on fairness of 8.87%. The corporate had income of $1 billion for the quarter, in comparison with analysts’ expectations of $997.30 million. Throughout the identical quarter within the earlier 12 months, the corporate earned $0.84 earnings per share. Cooper Corporations’s quarterly income was up 7.8% on a year-over-year foundation.
Analysts Set New Value Targets
A number of analysis companies just lately commented on COO. Needham & Firm LLC reissued a “maintain” ranking on shares of Cooper Corporations in a analysis notice on Thursday. Wells Fargo & Firm boosted their value goal on shares of Cooper Corporations from $110.00 to $115.00 and gave the inventory an “chubby” ranking in a analysis notice on Thursday. Jefferies Monetary Group raised shares of Cooper Corporations from a “maintain” ranking to a “purchase” ranking and boosted their value goal for the inventory from $107.00 to $115.00 in a analysis notice on Tuesday, July sixteenth. Robert W. Baird boosted their value goal on shares of Cooper Corporations from $118.00 to $125.00 and gave the inventory an “outperform” ranking in a analysis notice on Thursday. Lastly, Piper Sandler upped their goal value on shares of Cooper Corporations from $115.00 to $120.00 and gave the inventory an “chubby” ranking in a analysis notice on Thursday. 4 equities analysis analysts have rated the inventory with a maintain ranking and ten have given a purchase ranking to the inventory. Based mostly on knowledge from MarketBeat, the corporate at present has a mean ranking of “Average Purchase” and a consensus value goal of $113.16.
Learn Our Newest Analysis Report on Cooper Corporations
Institutional Buying and selling of Cooper Corporations
A lot of hedge funds and different institutional buyers have just lately added to or diminished their stakes within the enterprise. Worldwide Belongings Funding Administration LLC bought a brand new stake in shares of Cooper Corporations within the fourth quarter price $44,397,000. CWM LLC elevated its stake in shares of Cooper Corporations by 16.4% within the fourth quarter. CWM LLC now owns 781 shares of the medical gadget firm’s inventory price $296,000 after buying a further 110 shares within the final quarter. Victory Capital Administration Inc. elevated its stake in shares of Cooper Corporations by 16.5% within the fourth quarter. Victory Capital Administration Inc. now owns 995,245 shares of the medical gadget firm’s inventory price $376,641,000 after buying a further 140,700 shares within the final quarter. Buckhead Capital Administration LLC elevated its stake in shares of Cooper Corporations by 4.8% within the fourth quarter. Buckhead Capital Administration LLC now owns 10,930 shares of the medical gadget firm’s inventory price $4,136,000 after buying a further 502 shares within the final quarter. Lastly, New York Life Funding Administration LLC elevated its stake in shares of Cooper Corporations by 0.6% within the fourth quarter. New York Life Funding Administration LLC now owns 7,783 shares of the medical gadget firm’s inventory price $2,945,000 after buying a further 49 shares within the final quarter. 24.39% of the inventory is owned by hedge funds and different institutional buyers.
Cooper Corporations Buying and selling Up 9.6 %
The inventory’s 50 day shifting common value is $90.97 and its 200-day shifting common value is $94.04. The corporate has a fast ratio of 1.14, a present ratio of 1.95 and a debt-to-equity ratio of 0.34. The inventory has a market capitalization of $20.63 billion, a PE ratio of 55.61, a PEG ratio of two.34 and a beta of 0.98.
About Cooper Corporations
The Cooper Corporations, Inc, along with its subsidiaries, develops, manufactures, and markets contact lens wearers. The corporate operates in two segments, CooperVision and CooperSurgical. The CooperVision section supplies spherical lense, together with lenses that appropriate close to and farsightedness; and toric and multifocal lenses comprising lenses correcting imaginative and prescient challenges, similar to astigmatism, presbyopia, and myopia within the Americas, Europe, Center East, Africa, and Asia Pacific.
Featured Tales
Obtain Information & Rankings for Cooper Corporations Every day – Enter your e-mail handle beneath to obtain a concise each day abstract of the most recent information and analysts’ rankings for Cooper Corporations and associated firms with MarketBeat.com’s FREE each day e-mail publication.